Chinese herbal formula for sjögren's syndrome dry mouth
Part of Immune system & allergy clinical trials.
This study tests a traditional Chinese herbal formula (Yiqi Yangyin) for people with primary Sjögren's syndrome who have dry mouth and fit a specific TCM pattern. It aims to see if the formula can safely and effectively reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 75
- Have a diagnosis of primary Sjögren's syndrome with significant dry mouth
- Have positive antibodies (like ANA or anti-SSA) or other immune markers in blood
- Fit the traditional Chinese medicine pattern of qi and yin deficiency
- Not have used certain immune-suppressing drugs or biologics in the past 1–6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called CM336 for people with active Sjögren's syndrome. It aims to see if the drug is safe and effective in reducing symptoms like joint pain and dryness when other treatments haven't worked well.
This study tests an investigational drug called JH013 for primary Sjögren's syndrome. It aims to reduce dryness and other symptoms like fatigue and joint pain, and may help people with moderate to severe disease activity.
This Phase 2 study tests how to measure changes in primary Sjögren’s syndrome symptoms and body activity. It may help researchers confirm which outcomes best reflect improvement and how different patient types respond to treatment.
This trial tests whether adding traditional Chinese medicine to standard care can help repair gland damage caused by Sjögren's syndrome. It is for people with primary Sjögren's who have a specific traditional Chinese medicine pattern called 'qi and yin deficiency'.
This study tests a new medicine called ICP-488 for people with primary Sjögren's syndrome. It may help reduce symptoms like dry eyes and dry mouth by calming the immune system. The trial lasts about 48 weeks and includes regular check-ups.
This study tests a new medicine called ESG206, which is designed to calm the immune system and reduce the symptoms of Sjögren's syndrome. If you join, you may get this medicine or a placebo, and the study will see if it safely helps with things like dry eyes and dry mouth.
Hear when a new Primary Sjögren's Syndrome (pSS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.